Trials / Conditions / Spinal Muscular Atrophy Type 3

Spinal Muscular Atrophy Type 3

18 registered clinical trials studyying Spinal Muscular Atrophy Type 3 — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Gait and Bone Health in SMA NCT07400198	Jacqueline Montes	—
Recruiting	A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular A NCT07047144	Scholar Rock, Inc.	Phase 2
Active Not Recruiting	Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Lim NCT06300996	Marco Capogrosso	N/A
Recruiting	Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type NCT06421831	GeneCradle Inc	Phase 1 / Phase 2
Recruiting	Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders NCT06839469	Columbia University	—
Active Not Recruiting	Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab NCT05626855	Scholar Rock, Inc.	Phase 3
Unknown	The Effect of Aerobic Exercise Training in Patients With Type III Spinal Muscular Atrophy NCT05544994	Istanbul Medipol University Hospital	N/A
Completed	Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinerse NCT05156320	Scholar Rock, Inc.	Phase 3
Completed	Spinal Cord Stimulation in Spinal Muscular Atrophy NCT05430113	Marco Capogrosso	N/A
Unknown	Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease NCT05272969	LMU Klinikum	—
Completed	Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders NCT04907162	LMU Klinikum	—
Completed	Wearable Technology to Assess Gait Function in SMA and DMD NCT04193085	Columbia University	—
Completed	An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy NCT03921528	Scholar Rock, Inc.	Phase 2
Terminated	Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3 NCT03819660	Catalyst Pharmaceuticals, Inc.	Phase 2
Active Not Recruiting	Spinraza in Adult Spinal Muscular Atrophy NCT03709784	Washington University School of Medicine	—
Terminated	Whole Body Vibration Therapy in Children With Spinal Muscular Atrophy NCT03056144	The Hong Kong Polytechnic University	N/A
Completed	Oxidative Capacity and Exercise Tolerance in Ambulatory SMA NCT02895789	Columbia University	—
Completed	Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3 NCT02227823	Centre Hospitalier Régional de la Citadelle	Phase 2